[HTML][HTML] Type I interferon-mediated autoinflammation due to DNase II deficiency
…, B Neven, P Nitschke, T Pascreau, S Pastore… - Nature …, 2017 - nature.com
Microbial nucleic acid recognition serves as the major stimulus to an antiviral response,
implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the …
implying a requirement to limit the misrepresentation of self nucleic acids as non-self and the …
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
…, K Pagava, V Panaviene, S Pastore… - The Lancet Child & …, 2019 - thelancet.com
Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…
Describing Kawasaki shock syndrome: results from a retrospective study and literature review
A Taddio, ED Rossi, L Monasta, S Pastore… - Clinical …, 2017 - Springer
Kawasaki shock syndrome (KSS) is a rare manifestation of Kawasaki disease (KD) characterized
by systolic hypotension or clinical signs of poor perfusion. The objectives of the study …
by systolic hypotension or clinical signs of poor perfusion. The objectives of the study …
[HTML][HTML] ANCA-associated vasculitis in childhood: recent advances
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic
diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, …
diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, …
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
…, Y Uziel, I Tirosh, L Harel, R Caorsi, S Pastore… - The Lancet, 2023 - thelancet.com
Background Juvenile idiopathic arthritis can be refractory to some or all treatment regimens,
therefore new medications are needed to treat this population. This trial assessed the …
therefore new medications are needed to treat this population. This trial assessed the …
The resurgence of rheumatic fever in a developed country area: the role of echocardiography
S Pastore, A De Cunto, A Benettoni, E Berton… - …, 2011 - academic.oup.com
Objectives. The annual incidence of ARF ranges from 5 to 51/100 000 population worldwide
in the 5- to 15-year age group. In the past, there was a decline in the incidence of ARF; …
in the 5- to 15-year age group. In the past, there was a decline in the incidence of ARF; …
[HTML][HTML] A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry
…, S Martino, AN Olivieri, G Fabio, S Pastore… - Pediatric …, 2017 - Springer
Background Behçet’s disease is a rare multi-systemic inflammatory disease with unknown
etiology which involves principally oral and genital mucosa, skin and eyes. Average age at …
etiology which involves principally oral and genital mucosa, skin and eyes. Average age at …
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases
…, C Esposito, M Lepretti, S Pastore… - Clinical & …, 2010 - academic.oup.com
Anti-transglutaminase antibodies are the diagnostic markers of coeliac disease. A role is
suggested for infectious agents in the production of anti-transglutaminase antibodies. The aim …
suggested for infectious agents in the production of anti-transglutaminase antibodies. The aim …
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis
…, C Bracaglia, DP Marafon, S Pastore… - The Journal of …, 2018 - jrheum.org
Objective. Anti-TNF-α agents have significantly changed the management of juvenile idiopathic
arthritis (JIA). We evaluated the safety and efficacy of adalimumab (ADA) and infliximab (…
arthritis (JIA). We evaluated the safety and efficacy of adalimumab (ADA) and infliximab (…
[HTML][HTML] Dealing with chronic non-bacterial osteomyelitis: a practical approach
…, M Pardeo, M Gregori, M Finetti, S Pastore… - Pediatric …, 2017 - Springer
Background Chronic Non-Bacterial Osteomyelitis (CNO) is an inflammatory disorder that
primarily affects children. Although underestimated, its incidence is rare. For these reasons, no …
primarily affects children. Although underestimated, its incidence is rare. For these reasons, no …